KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) Shares Outstanding (2019 - 2025)

Clover Health Investments (CLOV) has disclosed Shares Outstanding for 4 consecutive years, with $473.3 million as the latest value for Q1 2022.

  • For the quarter ending Q1 2022, Shares Outstanding changed N/A year-over-year to $473.3 million, compared with a TTM value of $473.3 million through Mar 2022, changed N/A, and an annual FY2021 reading of $352.6 million, up 295.31% over the prior year.
  • Shares Outstanding was $473.3 million for Q1 2022 at Clover Health Investments, up from $470.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $473.3 million in Q1 2022 and bottomed at $42.7 million in Q4 2019.
  • Average Shares Outstanding over 4 years is $216.9 million, with a median of $142.3 million recorded in 2021.
  • Peak annual rise in Shares Outstanding hit 212.61% in 2021, while the deepest fall reached 67.32% in 2021.
  • Year by year, Shares Outstanding stood at $45.6 million in 2019, then soared by 95.27% to $89.0 million in 2020, then tumbled by 99.98% to $14730.0 in 2021, then soared by 3213087.49% to $473.3 million in 2022.
  • Business Quant data shows Shares Outstanding for CLOV at $473.3 million in Q1 2022, $14730.0 in Q4 2021, and $278.3 million in Q3 2021.